Molecular pathways in colorectal cancer
- PMID: 22694276
- DOI: 10.1111/j.1440-1746.2012.07200.x
Molecular pathways in colorectal cancer
Abstract
Colorectal cancer (CRC) is the second most common newly diagnosed cancer and accounts for the second highest number of cancer related deaths in Australia, the third worldwide and of increasing importance in Asia. It arises through cumulative effects of inherited genetic predispositions and environmental factors. Genomic instability is an integral part in the transformation of normal colonic or rectal mucosa into carcinoma. Three molecular pathways have been identified: these are the chromosomal instability (CIN), the microsatellite instability (MSI), and the CpG Island Methylator Phenotype (CIMP) pathways. These pathways are not mutually exclusive, with some tumors exhibiting features of multiple pathways. Germline mutations are responsible for hereditary CRC syndromes (accounting for less than 5% of all CRC) while a stepwise accumulation of genetic and epigenetic alterations results in sporadic CRC. This review aims to discuss the genetic basis of hereditary CRC and the different pathways involved in the process of colorectal carcinogenesis.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Similar articles
-
Clinical and molecular features of young-onset colorectal cancer.World J Gastroenterol. 2016 Feb 7;22(5):1736-44. doi: 10.3748/wjg.v22.i5.1736. World J Gastroenterol. 2016. PMID: 26855533 Free PMC article. Review.
-
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.Gastroenterology. 2007 Jan;132(1):127-38. doi: 10.1053/j.gastro.2006.09.018. Epub 2006 Sep 20. Gastroenterology. 2007. PMID: 17087942
-
[Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].Orv Hetil. 2006 Mar 12;147(10):449-55. Orv Hetil. 2006. PMID: 16573174 Review. Hungarian.
-
Pathways of colorectal carcinogenesis.Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):97-102. doi: 10.1097/PAI.0b013e31827ea79e. Appl Immunohistochem Mol Morphol. 2013. PMID: 23417071 Review.
-
[Genetic aspects of colorectal carcinogenesis].Wiad Lek. 2004;57(1-2):74-9. Wiad Lek. 2004. PMID: 15181754 Review. Polish.
Cited by
-
In vivo Bioluminescence-Based Monitoring of Liver Metastases from Colorectal Cancer: An Experimental Model.J Microsc Ultrastruct. 2019 Jul-Sep;7(3):136-140. doi: 10.4103/JMAU.JMAU_51_18. J Microsc Ultrastruct. 2019. PMID: 31548925 Free PMC article.
-
The role of PDGFRA as a therapeutic target in young colorectal cancer patients.J Transl Med. 2021 Oct 26;19(1):446. doi: 10.1186/s12967-021-03088-7. J Transl Med. 2021. PMID: 34702313 Free PMC article.
-
Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria.Hered Cancer Clin Pract. 2023 Oct 20;21(1):21. doi: 10.1186/s13053-023-00266-0. Hered Cancer Clin Pract. 2023. PMID: 37864171 Free PMC article. Review.
-
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.Front Oncol. 2023 Sep 8;13:1223915. doi: 10.3389/fonc.2023.1223915. eCollection 2023. Front Oncol. 2023. PMID: 37746286 Free PMC article.
-
Frequent intragenic rearrangements of DPYD in colorectal tumours.Pharmacogenomics J. 2015 Jun;15(3):211-8. doi: 10.1038/tpj.2014.68. Epub 2014 Oct 28. Pharmacogenomics J. 2015. PMID: 25348620
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
